1,595
Views
1
CrossRef citations to date
0
Altmetric
Case Report

A family with mental disorder as the first symptom finally confirmed with Gerstmann–Sträussler–Scheinker disease with P102L mutation in PRNP gene – case report

, , , , &
Pages 37-43 | Received 25 Oct 2022, Accepted 11 Jan 2023, Published online: 22 Feb 2023

References

  • Katherine Young H, Clark B, Pedro Piccardo SR, et al. Gerstmann–Sträussler–Scheinker disease with the PRNP P102L mutation and valine at codon129. Mol Brain Res. 1997;Vol. 44:147–150. PMID: 33879752.
  • Riudavets MA, Sraka MA, Schultz M, et al. Gerstmann–Sträussler–Scheinker syndrome with variable phenotype in a new kindred with PRNP-P102l mutation. Brain Pathol. 2014;24:142–147.
  • Jansen C, Parchi P, Capellari S, et al. Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathol. 2010;119:189–197.
  • AR G, GD F, Aresi A, et al. Atypical frontotemporal dementia a new clinical phenotype of Gerstmann–Straussler–Scheinker disease with the PrP-P102L mutation. Description of a previously unreported Italian family. Neurol Sci. 2008;29:405–410.
  • Araujo AQ. Prionic diseases. Arq Neuropsiquiatr. 2013;71:731–737.
  • Imran M, Mahmood S. An overview of human prion diseases. Virol J. 2011;8:559.
  • Ling L, Cai X, Shu Y, et al. A family with hereditary cerebellar ataxia finally confirmed as Gerstmann–Sträussler–Scheinker syndrome with P102L mutation in PRNP gene. Neuroences. 2017;22:138–142.
  • Jones M, Odunsi S, du Plessis D, et al. Gerstmann–Sträussler–Scheinker disease: novel PRNP mutation and VGKC-complex antibodies. Neurology. 2014;82:2107–2111. et al.
  • Liberski PP. Gerstmann–Sträussler–Scheinker disease. Adv Exp Med Biol. 2012;724:128–137.
  • Peoc’h K, Levavasseur E, Delmont E, et al. Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders. Hum Mol Genet. 2012;21(26):5417–5428.
  • Popova SN, Tarvainen I, Capellari S, et al. Divergent clinical and neuropathological phenotype in a Gerstmann–Sträussler–Scheinker P102L family. Acta Neurol Scand. 2012;126:315–323.
  • Takazawa T, Ikeda K, Ito H, et al. A distinct phenotype of leg hyperreflexia in a Japanese family with Gerstmann–Sträussler–Scheinker syndrome (P102L). Intern Med. 2010;49:339–342.
  • Webb TE, Poulter M, Beck J, et al. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain. 2008;131:2632–2646.
  • Hong-Fu L, Liu Z-J, Dong H-L, et al. Clinical features of Chinese patients with Gerstmann–Sträussler–Scheinker identified by targeted next-generation sequencing[J]. Neuro Agi. 2016;49:216.e1–216.e5.
  • Kim MO, Takada LT, Wong K, et al. Genetic PrPrion Diseases. Cold Spring Harb Perspect Biol. 2018;10:a033134.
  • Franko E, Wehner T, Joly O, et al. Quantitative EEG parameters correlate with the progression of human prion diseases. J Neurol Neurosurg. 2016;87:1061–1067.